Kesselring Felix/Kohler Stefan, Is clampdown on Swiss stem cell therapies justified?, in: China Business Law Journal Volume 7 Issue 4, April 2016, S. 78 f.
Kategorien: Gesundheitswesen, Life Sciences, Pharma, Biotechnologie, Public Sector und Regulatory